Business
Correction: KRTL Holding Group Congratulates SIGMA on National Recognition for Pharmaceutical Excellence in Bolivia
Correction: KRTL Holding Group Congratulates SIGMA on National Recognition for Pharmaceutical Excellence in Bolivia.
About this update from Krtl Holding Group, Inc
[{"type":"text","content":"KRTL\r\nHolding Group Inc. (OTC: KRTL) (\"KRTL\" or the \"Company\")\r\nproudly congratulates its majority-owned subsidiary, Industria\r\nQuímico-Farmacéutica SIGMA Corp., for receiving the PATUJÚ Award from Bolivia’s\r\nMinistry of Justice and Institutional Transparency in collaboration with the Chamber\r\nof Industry, Commerce, and Services of Cochabamba (ICAM).\r\nThis\r\nprestigious recognition was presented to SIGMA under the category of Implementation\r\nof Regulatory Compliance Components, highlighting its organizational commitment\r\nto transparency, anti-corruption standards, and corporate ethics. The PATUJÚ\r\nAward is granted to institutions that exemplify Bolivia’s highest standards of\r\nintegrity through compliance programs that protect both internal operations and\r\npublic trust.\r\n“This\r\nrecognition reflects the values that define SIGMA’s leadership—integrity,\r\naccountability, and service,” said Cesar Herrera, CEO of KRTL Holding Group\r\nInc. “It’s a rare and distinguished honor that validates our belief in\r\npartnering with organizations that lead by example.”\r\nAs\r\npart of Bolivia’s “Hecho en Bolivia” (Made in Bolivia) initiative, the award\r\npromotes ethical leadership across industries by spotlighting companies that\r\nincorporate best practices in governance, transparency, and corruption\r\nprevention. SIGMA’s internal compliance framework—developed under the\r\nleadership of Patricia Wilstermann—demonstrates how pharmaceutical companies\r\ncan build operational excellence around both business performance and social\r\nresponsibility.\r\n“SIGMA\r\nhas always worked with integrity and purpose, and this recognition belongs to\r\nour entire team,” said Patricia Wilstermann, CEO of SIGMA Corp. “We remain\r\ncommitted to building a corporate culture that delivers transparency, trust,\r\nand long-term impact.”\r\nThis\r\ndistinction underscores SIGMA’s role not only as a trusted pharmaceutical\r\npartner but also as a model of ethical business practice in Bolivia and beyond.\r\nFor KRTL, this award reinforces the strength of its international strategy,\r\nwhich prioritizes values-driven partnerships in every market.\r\nThe\r\naward was formally announced by ICAM and can be viewed via its official\r\nLinkedIn post:\r\nhttps://www.linkedin.com/posts/icamcbba_hechoenbolivia-activity-7387648988000460800-3M...